Context Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Context Therapeutics generated cash of -$21,047,618, which is less than the previous year. Cash used in financing activities reached the amount of $0 last year. Net change in cash is therefore -$21,047,618.
Cash Flow
| 2019 | -2.83M | 0 | 1.95M |
|---|---|---|---|
| 2020 | -1.03M | 0 | 1.14M |
| 2021 | -8.79M | -250K | 58.39M |
| 2022 | -13.54M | -536.83K | -102.07K |
| 2023 | -21.04M | 0 | 0 |
CNTX Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 35.49M | 49.68M | 341.03K | 226.60K | 1.10M |
Operating activities | |||||
Net income | -23.96M | -14.83M | -10.45M | 6.64M | -6.38M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 12.04K | 9.26K | 0 | 0 | 0 |
Stock-based compensation expense | 1.07M | 976.44K | 511.07K | 219.24K | 775.25K |
| Deferred income tax benefit | 1.07M | 976.44K | 511.07K | 219.24K | 775.25K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 1.44M | -787.89K | -866.00K | 556.27K | 505.41K |
Cash generated by operating activities | -21.04M | -13.54M | -8.79M | -1.03M | -2.83M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -536.83K | -250K | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | -536.83K | -250K | 0 | 0 |
Financing activities | |||||
Common Stock Issued | 0 | 309.39K | 53.41M | 1M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -149.05K | 0 |
Cash used in financing activities | 0 | -102.07K | 58.39M | 1.14M | 1.95M |
Net Change In Cash | -21.04M | -14.18M | 49.34M | 114.43K | -878.69K |
Cash at end of period | 14.44M | 35.49M | 49.68M | 341.03K | 226.60K |
| Data source | Data source | Data source |